
PBH Stock Forecast & Price Target
PBH Analyst Ratings
Bulls say
Prestige Consumer is expected to achieve their EBITDA target and generate $100M in FCF in 2026, driven by investments in internal growth and potential divestment of non-core assets. However, they face challenges such as input cost inflation and tariffs that may affect their ability to achieve these targets. Their focus on higher-margin operations and the potential impact of broader inflation concerns may also have an impact on future performance.
Bears say
Prestige Consumer is a well-established company with a diverse portfolio of leading brands that generate most of its revenue in the North American market. Despite its strong brand recognition and support from medical professionals, high working capital requirements and lower FCF conversion compared to its Canadian peers are major concerns. The potential divestiture of its PFD segment could provide some positive catalyst, but uncertain timing and persistent cost inflation may hinder its profitability and valuation. The investments in internal growth may take some time to provide significant returns, and its above-average valuation and leverage may limit investor interest.
This aggregate rating is based on analysts' research of Prestige Brands Holdings and is not a guaranteed prediction by Public.com or investment advice.
PBH Analyst Forecast & Price Prediction
Start investing in PBH
Order type
Buy in
Order amount
Est. shares
0 shares